Tim McCrystal is the co-chair of the health care practice group. Tim has over thirty years of experience advising health care and life sciences companies and investors on complex and innovative matters, from unprecedented and innovative models of care delivery to highly complicated and unique transactions. Tim has negotiated numerous health care affiliations, mergers and acquisitions, joint ventures, hospital-physician relationships, medical practice acquisitions, formation and reorganization of multi-institutional health care systems. Tim has also been advising clients on novel regulatory issues related to the expansion of telehealth and the use of data and artificial intelligence to improve access to care.
Tim has extensive experience in structuring innovative payment models, including vertical integration, value-based health care, digital health and telehealth. He has developed innovative business structures that enabled clients to create integrated networks and delivery systems that capitalize on economies of scale to successfully navigate risk-based contracting and value-based care payment models.
The breadth of Tim’s practice affords him a unique market perspective and the ability to recognize the trends within the industry and advise health care and life sciences clients on shifts within the industry. Recently, he has been guiding clients through the quickly expanding patchwork of emerging state laws and regulations aimed at managing competition, quality, access and cost in the context of health care transactions.
Tim is also recognized as a leading counsel on privacy and cybersecurity. He regularly advises clients on the full array of data privacy, protection and security matters relating to the HIPAA privacy and security rules. Tim has represented clients in highly publicized settlements with the United States Department of Health and Human Services, Office for Civil Rights stemming from alleged data breaches relating to the loss or theft of protected health information.
- Harvard Pilgrim Health Care. Advised Harvard Pilgrim Health Care in its combination with Health Plan Holdings, formerly named Tufts Health Plan, representing the coming together of two of New England’s most iconic non-profit health care companies to form Point32Health.
- Gentiva. Represented Gentiva, a home health care, hospice and related health services provider and wholly owned subsidiary of Kindred Healthcare, on the regulatory and compliance matters related to its successful acquisition of ProMedica’s home health, palliative and hospice businesses.
- Emmes Company. Represented Emmes Company, a New Mountain Capital portfolio company and global, full-service clinical research organization, in its add-on acquisition of Essex Management, a biomedical informatics and health information technology-focused consultancy firm.
- Large Health System. Represented one of the largest systems in the US in structuring a multi-year joint venture with one of the largest renal care companies running more than 2,300 centers in 11 countries.
- DentaQuest. Represented DentaQuest in its $2.475 billion sale to Sun Life Financial, Inc.
- Catalyst Institute. Represented the nonprofit parent company of DentaQuest, Catalyst Institute, in connection with the sale of a minority interest in DentaQuest to Centerbridge Partners, a private equity firm.
- Norton Healthcare. Represented Norton Healthcare, a diversified Kentucky health system, in connection with restating its pediatric academic and clinical affiliations with the University of Louisville (“University”), acquiring a pediatric faculty practice operated by the University and affiliates, and developing a comprehensive research affiliation agreement with the University and its affiliates.
- Berkshire Partners. Advised Berkshire Partners in its agreement to make a significant investment in Ensemble Health Partners, a leading provider of technology-enabled revenue cycle management solutions for health systems, including hospitals and affiliated physician groups.
- Real Chemistry. Represented New Mountain Capital portfolio company Real Chemistry, a global health innovation company utilizing AI, in the acquisition of TI Health, a data-driven marketing and predictive analytics company that delivers omnichannel healthcare provider engagement insights and activation solutions for pharmaceutical and life sciences brands.
- Bain Capital Private Equity. Advised on the health care regulatory aspects of Bain Capital’s majority investment in InnovaCare Health, an integrated primary care provider network, annually treating more than 250,000 patients and supporting physicians who collectively serve more than 27,000 Medicare Advantage members.
- Welsh, Carson, Anderson & Stowe (“WCAS”). Represented WCAS in a joint venture with Humana’s CenterWell Senior Primary Care to deploy up to $1.2 billion of capital to develop approximately 100 new value-based primary care clinics for Medicare patients between 2023 and 2025.
- Help at Home. Represented Vistria Group portfolio company Help at Home, a home care services provider for seniors and people living with disabilities, on the regulatory aspects of the Recco Home Care Services, Inc., a New York licensed health care services agency and fiscal intermediary for new York’s consumer-directed personal assistance program.
- LifeStance Health Group. Represented LifeStance Health Group, one of the nation's largest providers of outpatient mental health care, in its $720 million initial public offering.
- Leading Northeast AMC. Represented a leading AMC in connection with the negotiation and settlement of an enforcement action by the OCR relating to the loss of certain documents containing protected health information by an employee.
- Nationally Renowned Specialty Hospital. Represented a teaching hospital in connection with the negotiation and settlement of an enforcement action by the OCR relating to the loss of a laptop containing unencrypted protected health information by a researcher.
- Large Health System. Represented a large health system in one of the largest putative class-action lawsuits arising from an alleged link between identity thefts claimed to have been experienced by former patients and personal information maintained in system files.